14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of NATCOPHARM.NS
Powered by GPT-4o
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

NATCO Pharma Limited stock price ended at ₹1,210.60 on Friday, after gaining 2.90%.
(Updated on Jun 14, 2024)

Buy or Hold candidate since Jun 05, 2024 Gain 19.25% PDF

The NATCO Pharma Limited stock price gained 2.90% on the last trading day (Friday, 14th Jun 2024), rising from ₹1,176.45 to ₹1,210.60. During the last trading day the stock fluctuated 4.95% from a day low at ₹1,171.00 to a day high of ₹1,229.00. The price has risen in 8 of the last 10 days and is up by 21.35% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 1 million more shares were traded than the day before. In total, 2 million shares were bought and sold for approximately ₹2.08 billion.

The stock has broken the wide and strong rising the short-term trend up and an even stronger rate of rising is indicated. For any reaction back there will now be support on the roof on the current trend broken at ₹1,096.79, a level that may pose a second chance to hit a runner.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

NATCOPHARM.NS Signals & Forecast

The NATCO Pharma Limited stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at ₹1,134.61 and ₹1,030.34. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Tuesday, June 04, 2024, and so far it has risen 24.76%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal.

Support, Risk & Stop-loss for NATCO Pharma Limited stock

NATCO Pharma Limited finds support from accumulated volume at ₹1,172.35 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved ₹58.00 between high and low, or 4.95%. For the last week, the stock has had daily average volatility of 4.16%.

The NATCO Pharma Limited stock is extremely overbought on RSI14 (77). Normally this may pose a good selling opportunity but since the stock has broken the trend up, the chance for a major correction due to high RSI is very small as the stock will find support at the trend broken.

Our recommended stop-loss: ₹1,168.71 (-3.46%) (This stock has medium daily movements and this gives medium risk. The RSI14 is 77 and this increases the risk substantially. There is a buy signal from a pivot bottom found 12 days ago.)

Trading Expectations (NATCOPHARM.NS) For The Upcoming Trading Day Of Tuesday 18th

For the upcoming trading day on Tuesday, 18th we expect NATCO Pharma Limited to open at ₹1,203.53, and during the day (based on 14 day Average True Range), to move between ₹1,169.66 and ₹1,251.54, which gives a possible trading interval of +/-₹40.94 (+/-3.38%) up or down from last closing price. If NATCO Pharma Limited takes out the full calculated possible swing range there will be an estimated 6.76% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ ₹1,172.35, some ₹38.25 (3.16%) from the current price of ₹1,210.60, our system finds the risk reward attractive.

Is NATCO Pharma Limited stock A Buy?

NATCO Pharma Limited holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.000 Hold/Accumulate Unchanged

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Opening Price for NATCO Pharma Limited of Tuesday, June 18, 2024

Fair opening price June 18, 2024 Current price
₹1,203.53 ( 0.584%) ₹1,210.60

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for NATCOPHARM.NS

Fibonacci Support & Resistance Levels

Level Price
R3 1,261.53 4.21%
R2 1,239.38 2.38%
R1 1,225.69 1.25%
Price 1,210.60
S1 1,181.38 -2.41%
S2 1,167.69 -3.54%
S3 1,145.53 -5.37%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0 -
R2 0 -
R1 0 -
Price 1,210.60
S1 1,172.35 -3.16%
S2 1,032.30 -14.73%
S3 1,015.20 -16.14%

NATCOPHARM Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Feb 26, 2024 Feb 26, 2024 Mar 04, 2024 ₹1.25 0.126%
2 Nov 24, 2023 Nov 24, 2023 Dec 14, 2023 ₹1.25 0.163%
3 Aug 22, 2023 Aug 22, 2023 Sep 08, 2023 ₹7.00 0.794%
4 Feb 21, 2023 Feb 21, 2023 Feb 21, 2023 ₹1.25 0.228%
5 Nov 21, 2022 Nov 21, 2022 Nov 21, 2022 ₹0.750 0.132%

FAQ

What is the symbol for NATCO Pharma Limited Stock and on which exchange is it traded?
The symbol for NATCO Pharma Limited is NATCOPHARM.NS and it is traded on the NSE (National Stock Exchange of India).

Should I buy or sell NATCO Pharma Limited Stock?
NATCO Pharma Limited holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy NATCO Pharma Limited Stock?
NATCO Pharma Limited Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy NATCO Pharma Limited Stock.

What's the current price of NATCO Pharma Limited Stock?
As of the end of day on the Jun 14, 2024, the price of an NATCO Pharma Limited (NATCOPHARM.NS) share was ₹1,210.60.

What is the 52-week high and low for NATCO Pharma Limited Stock?
The 52-week high for NATCO Pharma Limited Stock is ₹1,229.00 and the 52-week low is ₹620.00.

What is the market capitalization of NATCO Pharma Limited Stock?
As of the Jun 14, 2024, the market capitalization of NATCO Pharma Limited is 216.831B.

When is the next earnings date for NATCO Pharma Limited?
The upcoming earnings date for NATCO Pharma Limited is Aug 07, 2024.
Click to get the best stock tips daily for free!

About NATCO Pharma Limited

NATCO Pharma Limited NATCO Pharma Limited, a pharmaceutical company, develops, manufactures, and markets finished dosage formulations and active pharmaceutical ingredients (APIs). It offers formulations in various therapeutic areas, including cancers of blood, liver, kidney, lung, brain, breast, ovary, etc.; and APIs in various categories, such as oncology, central nervous system, pain management, and CV care. The company also offers orthopedic products comprising bi... NATCOPHARM.NS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT